Key result
Gene expression of IFN-γR1 in peripheral blood mononuclear cells was significantly increased in patients with slow coronary flow compared to healthy controls (P<0.0001).
Why the study?
Does gene expression of IFN-γ receptor subunits differ in patients with slow coronary flow compared to healthy controls?
Case-Control (n=45)
Does gene expression of IFN-γ receptor subunits differ in patients with slow coronary flow compared to healthy controls?
p-value: p=<0.0001
Increased gene expression of IFN-γR1 in peripheral blood mononuclear cells is associated with slow coronary flow, suggesting a potential inflammatory mechanism involving endothelial dysfunction.
Summary Background: Slow coronary flow (SCF) is a coronary artery disorder characterized with delayed opacification of epicardial coronary arteries without obstructive coronary disease. The pathophysiological mechanisms of SCF remain un clear. One of the possible mechanisms that may participate in the pathology of SCF is endothelial dysfunction related to the inflammatory process. Interferon gamma (IFN-γ) is an inflammatory cytokine that acts through its specific receptor composed of two subunits, IFN-γR1 and IFN-γR2. Trans criptional activity of the gene encoding these subunits influences IFN-γ activity. This study aimed to investigate the gene expression of IFN-γ receptor subunits in peripheral blood mononuclear cells (PBMC) from patients with SCF. Methods: The study was performed with 30 patients (22 male/8 female) aged 35–76 (52.8±11.7 years) with SCF and 15 sex-(11 male/4 female), Body Max Index (BMI)-and age-matched (54.73±9.42 years) healthy subjects. Total mRNA was extracted from PBMC and was determined by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The relative expression values (2 −ΔΔCt ) between control and case groups were determined and the Mann-Whitney U test was used for statistical analysis. Results: There was a significant increase in the gene expression of IFN-γR1 in PBMC from SCF patients vs . controls (P< 0.0001); but the differences in IFN-γR2 gene expression were statistically insignificant between patient and control groups (P= 0.853). Conclusions: It can be concluded that IFN-γR1 gene expression may influence the function of microvasculature and thereby contribute to the pathophysiology of SCF.
No takes yet. Share an insight, caveat, or question.
Faramarz-Gaznagh et al. (2016) conducted a case-control in Slow coronary flow (n=45). Gene expression of IFN-γ receptor subunits in PBMC vs. Healthy subjects was evaluated on Gene expression of IFN-γR1 and IFN-γR2 in PBMC (p=<0.0001). Gene expression of IFN-γR1 in peripheral blood mononuclear cells was significantly increased in patients with slow coronary flow compared to healthy controls (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: